This is the authors' abstract. We don't add key points for this paper.
To describe current trends in pharmacologic management of paroxysmal sympathetic hyperactivity (PSH) among pediatric physicians practicing in North America.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Koshiya et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: